Prostate Cancer News on BioPortfolio

NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer

SALT LAKE CITY Feb. 20 2018 GLOBE NEWSWIRE Myriad Genetics Inc. NASDAQMYGN today announced that the National Comprehensive Cancer Network NCCN has updated its medical guidelines for prostate cancer treatment to broadly include biomarker testing in pros...

MagForce AG Publishes Shareholder Letter

DGAPNews MagForce AG Key words Miscellaneous19.02.2018 0830 The issuer is solely responsible for the content of this announcement.MagForce AG Publishes Shareholder Letter USA FDA IDE Approval to conduct a clinical trial with NanoThermR therapy as focal a...

FDA Approves First Treatment for Nonmetastatic CRPC

The US Food and Drug Administration FDA has approved the oral agent apalutamide Erleada for the treatment of nonmetastatic castrationresistant prostate cancer. The oral androgenreceptor inhibitor is the first FDAapproved treatment for patients with nonmeta...

Pages